A detailed history of Burt Wealth Advisors transactions in Amgen Inc stock. As of the latest transaction made, Burt Wealth Advisors holds 2,842 shares of AMGN stock, worth $751,680. This represents 0.23% of its overall portfolio holdings.

Number of Shares
2,842
Previous 2,879 1.29%
Holding current value
$751,680
Previous $899,000 1.78%
% of portfolio
0.23%
Previous 0.24%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$309.38 - $337.38 $11,447 - $12,483
-37 Reduced 1.29%
2,842 $915,000
Q2 2024

Jul 16, 2024

SELL
$262.75 - $319.31 $23,910 - $29,057
-91 Reduced 3.06%
2,879 $899,000
Q1 2024

Apr 18, 2024

BUY
$268.87 - $324.56 $57,807 - $69,780
215 Added 7.8%
2,970 $844,000
Q2 2023

Jul 18, 2023

SELL
$214.27 - $253.37 $642 - $760
-3 Reduced 0.11%
2,755 $611,000
Q1 2023

Apr 13, 2023

BUY
$225.79 - $275.2 $677 - $825
3 Added 0.11%
2,758 $666,000
Q4 2022

Jan 17, 2023

BUY
$229.03 - $291.01 $630,977 - $801,732
2,755 New
2,755 $724,000
Q1 2022

Apr 19, 2022

BUY
$219.27 - $242.57 $604,088 - $668,280
2,755 New
2,755 $666,000
Q4 2021

Jan 13, 2022

SELL
$198.88 - $227.6 $468,362 - $535,998
-2,355 Closed
0 $0
Q2 2021

Jul 14, 2021

SELL
$233.58 - $259.14 $49,051 - $54,419
-210 Reduced 8.19%
2,355 $574,000
Q3 2020

Nov 10, 2020

SELL
$234.65 - $260.95 $938 - $1,043
-4 Reduced 0.16%
2,565 $652,000
Q2 2020

Aug 05, 2020

BUY
$197.81 - $242.74 $791 - $970
4 Added 0.16%
2,569 $606,000
Q1 2020

Apr 29, 2020

SELL
$182.24 - $241.7 $18,224 - $24,170
-100 Reduced 3.75%
2,565 $520,000
Q3 2019

Oct 31, 2019

SELL
$174.11 - $208.62 $30,469 - $36,508
-175 Reduced 6.16%
2,665 $516,000
Q1 2019

Apr 24, 2019

SELL
$180.87 - $203.88 $31,652 - $35,679
-175 Reduced 5.8%
2,840 $540,000
Q3 2017

Nov 09, 2017

SELL
$167.29 - $191.0 $4,182 - $4,775
-25 Reduced 0.82%
3,015 $562,000
Q2 2017

Aug 07, 2017

BUY
N/A
3,040
3,040 $523,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Burt Wealth Advisors Portfolio

Follow Burt Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burt Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Burt Wealth Advisors with notifications on news.